Previous studies have shown that overexpression of LOX and LOXL2 can increase the abnormal crosslinking of collagen, promote fibrosis remodeling, and accelerate the malignant progression of the tumor [60–62]. The gene discussed is LOXL2; the disease is neoplasm.